Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiologyheart failure, electrophysiologyhypertension, structural heart disease, use of pharmaceuticals, and COVID-19.   

US life expectancy falls, primarily due to COVID-19

The numbers are worse for men compared to women, according to a new CDC report. 

‘Low-trust’ providers inadvertently increase pain in patients undergoing diagnostic testing

The effect shows up on functional MRI as increased brain activity in regions involved in pain, emotion and attention—not only during the procedure but also afterward, when patients remember the experience and score its discomfort level.

JenaValve Technology transfemoral TAVR

JenaValve raises $100M for its transfemoral TAVR system for severe aortic regurgitation

After finding success in Europe, the company is focused on gaining FDA approval for its Trilogy Heart Valve System and launching the device in the United States. 

Thumbnail

New expert guidelines highlight the importance of quickly diagnosing and treating CIED infections

Though removal of the affected CIED is typically the smartest treatment option—and one supported by specialty groups all over the world—a majority of patients keep living with the device, often resulting in hospitalization or even death.

How AI can boost care for female heart attack patients

Researchers used data from more than 420,000 patients to develop a new AI-powered risk score that could help women receive much better care. 

An overview of artificial intelligence (AI) in radiology with Keith Dreyer with the ACR. Images shows a COVID-19 lung CT scan reconstruction from Siemens Healthineers. #AI #radAI #ACR

AI speeds, improves chest X-ray interpretations

Six radiologists interpreting around 500 chest radiographs with an assist from AI bested unaided radiologists in measures of efficiency and/or accuracy in a new comparative performance study.    

Affera Inc Medtronic $925 million catheter ablation atrial fibrillation (AFib)

Medtronic completes acquisition of heart rhythm tech company in a deal reportedly worth $925M

Affera’s portfolio includes interventional solutions such as the Affera Prism-1 mapping and navigation platform, designed to help electrophysiologists diagnose heart rhythm issues, and the Sphere-9 cardiac ablation catheter. 

The Medtronic CoreValve Evolut and the Edwards Lifesciences Sapien 3 TAVR valves.

TAVR's success has changed how cardiologists and surgeons view aortic valve replacement

The standard-of-care thinking on TAVR has shifted from getting a valve implanted and managing immediate complications to looking decades down the road and considering the patient's long-term health.